Figure 1.

Schematic outline showing the potential interaction between E5, E6, and E7 of high-risk HPV oncoproteins with their intermediate proteins as well as their signaling pathways which can deregulate PD-1 and PD-L1 expression patterns, consequently leading to compromised immunity.